Expertise in
2
conditions

Dr. Salil U. Nadkarni

Family Medicine
1015 N Kings Rd, Suite 108, 
West Hollywood, CA 
Expertise in
2
conditions
1015 N Kings Rd, Suite 108, 
West Hollywood, CA 

Overview

Salil Nadkarni is a primary care provider, practicing in Family Medicine in West Hollywood, California.

Dr. Nadkarni is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Migraine with Brainstem Aura, Familial Hemiplegic Migraine, and Migraine.

He is actively involved in clinical research, participating in 8 clinical trials.

Specialties

Family Medicine

Licenses

Adult Medicine in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

1015 N Kings Rd, Suite 108, West Hollywood, CA 90069

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test
Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test
Enrollment Status: Completed
Publish Date: January 11, 2021
Intervention Type: Device
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: August 19, 2020
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: March 13, 2018
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 7 Less Clinical Trials
Similar Doctors
Expertise in
9
conditions
Dr. Joshua J. Solomon
Family Medicine
Expertise in
9
conditions
Dr. Joshua J. Solomon
Family Medicine

Playa Vista Medical Offices

5300 Mcconnell Ave, 
Los Angeles, CA 
 (8.0 miles away)
833-574-2273
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joshua Solomon is a primary care provider, practicing in Family Medicine in Los Angeles, California. Dr. Solomon is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Rheumatoid Lung Disease, Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, and Endoscopy. Dr. Solomon is currently accepting new patients.

Expertise in
15
conditions
Dr. Robert Bolan
Family Medicine
Expertise in
15
conditions
Dr. Robert Bolan
Family Medicine

Los Angeles LGBT Center

1625 Schrader Blvd, 
Los Angeles, CA 
 (2.4 miles away)
323-993-7500
Languages Spoken:
English
See accepted insurances

Robert Bolan is a primary care provider, practicing in Family Medicine in Los Angeles, California. Dr. Bolan is highly rated in 15 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Gonorrhea, Syphilis, and Myelitis.

Expertise in
96
conditions
Dr. Yuan Q. Liu
Family Medicine
Expertise in
96
conditions
Dr. Yuan Q. Liu
Family Medicine
701 S Atlantic Blvd Ste 100, 
Monterey Park, CA 
 (13.3 miles away)
626-300-9980
Languages Spoken:
English
See accepted insurances

Yuan Liu is a primary care provider, practicing in Family Medicine in Monterey Park, California. Dr. Liu is highly rated in 96 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Lung Adenocarcinoma, Arthritis, Liver Transplant, and Tissue Biopsy.

Frequently Asked Questions about Dr. Salil U. Nadkarni

How do I make an appointment with Dr. Salil U. Nadkarni?

You can book an appointment with Dr. Salil U. Nadkarni by calling their office at 312-890-6428. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Salil U. Nadkarni a top-rated expert for Migraine with Brainstem Aura?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Salil U. Nadkarni is classified as an Advanced expert for Migraine with Brainstem Aura, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Salil U. Nadkarni specialize in?

While Dr. Salil U. Nadkarni is a Family Medicine, they have specific expertise in Migraine with Brainstem Aura, Familial Hemiplegic Migraine, and Migraine. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Salil U. Nadkarni accept my insurance?

Dr. Salil U. Nadkarni accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 312-890-6428 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nadkarni's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile